Material Type

• Blood (whole) (2)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (3)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Other (2)
• Plasma (single spun) (5)
• Saliva (3)
• Serum (4)
• Swab medium (2)
• Urine (first morning) (1)
• Urine (random) (3)

Microscopic Assessment

• Affected (1)
• Not applicable (6)

Storage Temperature

• RT (2)
• -35°C to -18°C (1)
• -85°C to -60°C (6)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (6)
• Followup records (5)
• Freezer temperature logs (3)
• Genomic datasets (1)
• Microbiological results (6)
• Participant Ethnicity (3)
• Physiological/biochemical measurements (4)
• Pre-analytical data (3)
• Quality indicators (3)
• Survey data (3)
• Treatment records (3)

Timeframe

• Immediate (3)
• 0 - 3 months (6)
• 3 - 6 months (3)
• > 6 months (1)

Participant Count

• 11 - 100 (2)
• 101 - 500 (5)
• 1001 - 3000 (1)

Sex

• Both sexes (6)

Age Range

• Young child (2 - 6 years) (1)
• Child (6 - 12 years) (1)
• Adolescent (12 - 18 years) (2)
• Young adult (18 - 40 years) (6)
• Adult (> 40 years) (1)

Biobank Services

• Ability to recontact (2)
• Cell culture (1)
• Data analytics (2)

Collection Type

• Case-control (1)
• Clinical Trial (2)
• Cross-sectional (1)
• Disease specific (3)

Consent Restriction

• No Commercial restriction (4)
• No Disease area restriction (4)
• No Genetic analysis restriction (5)
• No Human genetic analysis restriction (6)
• No restrictions (1)
• No Project specific restriction (6)
• No Scope of use restriction (2)

Collection Status

• Completed (3)
• In progress (3)

Access Condition

• Open to applicants (4)
• Open only through collaboration (3)

Country

• Belgium (1)
• Democratic Republic of the Congo (2)
• France (1)
• Peru (1)
• South Africa (1)

County